false Q1 --12-31 0001487197 0001487197 2025-01-01 2025-03-31 0001487197 2025-04-28 0001487197 2025-03-31 0001487197 2024-12-31 0001487197 2024-01-01 2024-03-31 0001487197 2023-12-31 0001487197 2024-03-31 0001487197 BRFH:PurchasesMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerAMember 2025-01-01 2025-03-31 0001487197 BRFH:PurchasesMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerAMember 2024-01-01 2024-03-31 0001487197 BRFH:PurchasesMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerBMember 2025-01-01 2025-03-31 0001487197 BRFH:PurchasesMember us-gaap:SupplierConcentrationRiskMember BRFH:ManufacturerBMember 2024-01-01 2024-03-31 0001487197 BRFH:PurchasesMember us-gaap:SupplierConcentrationRiskMember BRFH:OtherManufacturersMember 2025-01-01 2025-03-31 0001487197 BRFH:PurchasesMember us-gaap:SupplierConcentrationRiskMember BRFH:OtherManufacturersMember 2024-01-01 2024-03-31 0001487197 BRFH:ManufacturingEquipmentMember 2025-03-31 0001487197 BRFH:ManufacturingEquipmentMember 2024-12-31 0001487197 BRFH:CustomerEquipmentMember 2025-03-31 0001487197 BRFH:CustomerEquipmentMember 2024-12-31 0001487197 us-gaap:ConstructionInProgressMember 2025-03-31 0001487197 us-gaap:ConstructionInProgressMember 2024-12-31 0001487197 2022-01-01 2022-12-31 0001487197 2021-01-01 2021-12-31 0001487197 us-gaap:RelatedPartyMember 2022-07-31 0001487197 2024-08-31 0001487197 2024-08-01 2024-08-31 0001487197 srt:MinimumMember 2025-03-31 0001487197 srt:MaximumMember 2025-03-31 0001487197 2023-07-01 2024-03-31 0001487197 2023-10-23 0001487197 2023-10-23 2023-10-23 0001487197 2023-12-19 0001487197 2023-12-19 2023-12-19 0001487197 2024-03-29 0001487197 2024-03-27 2024-03-29 0001487197 us-gaap:CommonStockMember 2023-12-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001487197 us-gaap:RetainedEarningsMember 2023-12-31 0001487197 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001487197 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001487197 us-gaap:CommonStockMember 2024-03-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001487197 us-gaap:RetainedEarningsMember 2024-03-31 0001487197 us-gaap:CommonStockMember 2024-12-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001487197 us-gaap:RetainedEarningsMember 2024-12-31 0001487197 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001487197 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001487197 us-gaap:CommonStockMember 2025-03-31 0001487197 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001487197 us-gaap:RetainedEarningsMember 2025-03-31 0001487197 BRFH:SecuritiesPurchaseAgreementsMember us-gaap:CommonStockMember 2025-02-05 2025-02-05 0001487197 BRFH:SecuritiesPurchaseAgreementsMember us-gaap:CommonStockMember 2025-02-05 0001487197 2024-01-01 2024-12-31 0001487197 BRFH:RestrictedStockAwardAndRestrictedStockUnitMember 2024-12-31 0001487197 BRFH:RestrictedStockAwardAndRestrictedStockUnitMember 2025-01-01 2025-03-31 0001487197 BRFH:RestrictedStockAwardAndRestrictedStockUnitMember 2025-03-31 0001487197 us-gaap:PerformanceSharesMember 2024-12-31 0001487197 us-gaap:PerformanceSharesMember 2025-01-01 2025-03-31 0001487197 us-gaap:PerformanceSharesMember 2025-03-31 0001487197 2025-02-01 2025-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2025

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________________ to ___________________

 

Commission File Number: 001-41228

 

BARFRESH FOOD GROUP INC.

(Exact name of registrant as specified in its charter)

 

Delaware   27-1994406

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     

3600 Wilshire Blvd., Suite 1720,

Los Angeles, California

  90010
(Address of principal executive offices)   (Zip Code)

 

310-598-7113

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.000001 par value   BRFH   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by the check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No 

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 15,920,047 shares as of April 28, 2025.

 

 

 

 
 

 

TABLE OF CONTENTS

 

    Page
Number
PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements. 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 14
Item 3. Quantitative and Qualitative Disclosures About Market Risk. 16
Item 4. Controls and Procedures. 17
     
PART II – OTHER INFORMATION 17
     
Item 1. Legal Proceedings. 17
Item 1A. Risk Factors. 17
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 17
Item 3. Defaults Upon Senior Securities. 17
Item 4. Mine Safety Disclosures. 17
Item 5. Other Information. 17
Item 6. Exhibits. 18
     
SIGNATURES 19

 

 

 

 

Item 1. Financial Statements.

 

Barfresh Food Group Inc.

Condensed Consolidated Balance Sheets

 

   March 31, 2025   December 31, 2024 
   (unaudited)   (audited) 
Assets          
Current assets:          
Cash  $1,872,000   $235,000 
Trade accounts receivable, net   1,499,000    829,000 
Other receivables   112,000    55,000 
Inventory, net   1,128,000    1,500,000 
Prepaid expenses and other current assets   189,000    104,000 
Total current assets   4,800,000    2,723,000 
Property, plant and equipment, net of depreciation   308,000    333,000 
Intangible assets, net of amortization   157,000    178,000 
Other non-current assets   72,000    84,000 
Total assets  $5,337,000   $3,318,000 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Line of credit  $-   $609,000 
Accounts payable   1,422,000    1,200,000 
Disputed co-manufacturer accounts payable (Note 4)   499,000    499,000 
Accrued expenses   188,000    142,000 
Accrued payroll and employee related expenses   239,000    67,000 
Financing agreements - current   103,000    99,000 
Total current liabilities   2,451,000    2,616,000 
Financing agreements   97,000    124,000 
Total liabilities   2,548,000    2,740,000 
           
Commitments and contingencies   -    - 
           
Stockholders’ equity:          
Preferred stock, $0.000001 par value, 400,000 shares authorized, none issued or outstanding   -    - 
Common stock, $0.000001 par value; 23,000,000 shares authorized; 15,920,047 and 14,746,172 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively   -    - 
Additional paid in capital   67,171,000    64,199,000 
Accumulated deficit   (64,382,000)   (63,621,000)
Total stockholders’ equity   2,789,000    578,000 
Total liabilities and stockholders’ equity  $5,337,000   $3,318,000 

 

See the accompanying notes to the condensed consolidated financial statements

 

3

 

 

Barfresh Food Group Inc.

Condensed Consolidated Statements of Operations

For the three months ended March 31, 2025 and 2024

(Unaudited)

 

   2025   2024 
Revenue  $2,930,000   $2,829,000 
Cost of revenue   2,030,000    1,659,000 
Gross profit   900,000    1,170,000 
Operating expenses:          
Selling, marketing and distribution   824,000    694,000 
General and administrative   747,000    855,000 
Depreciation and amortization   67,000    67,000 
Total operating expenses   1,638,000    1,616,000 
Loss from operations   (738,000)   (446,000)
Interest expense   23,000    3,000 
Net loss  $(761,000)  $(449,000)
           
Per share information - basic and fully diluted:          
Weighted average shares outstanding   15,387,665    14,500,863 
Net loss per share  $(0.05)  $(0.03)

 

See the accompanying notes to the condensed consolidated financial statements

 

4

 

 

Barfresh Food Group Inc.

Consolidated Statements of Cash Flows

For the three months ended March 31, 2025 and 2024

(Unaudited)

 

   2025   2024 
Net loss  $(761,000)  $(449,000)
Adjustments to reconcile net loss to net cash used in operating activities          
           
Stock-based compensation   158,000    366,000 
Depreciation and amortization   74,000    74,000 
Gain on asset disposal   -    - 
Amortization of line of credit discount   4,000    - 
Changes in assets and liabilities          
Accounts receivable   (670,000)   (545,000)
Other receivables   (57,000)   140,000 
Inventories   372,000    (70,000)
Prepaid expenses and other assets   (66,000)   (107,000)
Accounts payable   222,000    (271,000)
Accrued expenses   218,000    93,000 
Net cash used in operating activities   (506,000)   (769,000)
           
Investing activities          
Purchase of property and equipment   (28,000)   - 
Net cash used in investing activities   (28,000)   - 
           
Financing activities          
Borrowings under line of credit   782,000    - 
Repayment of line of credit   (1,402,000)   - 
Issuance of convertible debt   -    65,000 
Financing agreement payments   (23,000)   - 
Issuance of common stock, net of $26,000 issuance cost   2,974,000    - 
Shares repurchased for income tax withholding under stock compensation program   (160,000)   (20,000)
Net cash provided by financing activities   2,171,000    45,000 
           
Net increase (decrease) in cash   1,637,000    (724,000)
Cash, beginning of period   235,000    1,891,000 
Cash, end of period  $1,872,000   $1,167,000 
           
Non-cash financing and investing activities:          
Convertible notes issued in exchange for trade payables  $-   $71,000 
Conversion of debt and interest to equity  $-   $136,000 
Financed acquisition of long-term assets  $-   $154,000 
           
Cash paid for interest  $19,000   $- 

 

See the accompanying notes to the condensed consolidated financial statements

 

5

 

 

Barfresh Food Group Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2025

(Unaudited)

 

Note 1. Description of the Business, Basis of Presentation, and Summary of Significant Accounting Policies

 

Barfresh Food Group Inc., (“we,” “us,” “our,” and the “Company”) was incorporated on February 25, 2010 in the State of Delaware. The Company is engaged in the manufacturing and distribution of ready-to-drink and ready-to-blend beverages, particularly, smoothies, shakes and frappes.

 

Basis of Presentation

 

The accompanying condensed consolidated financial statements are unaudited, except for the condensed balance sheet as of December 31, 2024. These unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the fiscal year ended December 31, 2024 included in the Company’s Annual Report on Form 10-K, as filed with the SEC on March 27, 2025. In management’s opinion, the unaudited interim condensed consolidated financial statements reflect all adjustments, which are of a normal and recurring nature, that are necessary for a fair presentation of financial results for the interim periods presented. Operating results for any quarter are not necessarily indicative of the results for the full fiscal year.

 

Principles of Consolidation

 

The consolidated financial statements include the financial statements of the Company and our wholly owned subsidiaries, Barfresh Inc. and Barfresh Corporation Inc. (formerly known as Smoothie, Inc.). All inter-company balances and transactions among the companies have been eliminated upon consolidation.

 

Use of Estimates

 

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.

 

Vendor Concentrations

 

The Company is exposed to supply risk as a result of concentration in its vendor base resulting from the use of a limited number of contract manufacturers. Purchases from the Company’s significant contract manufacturers as a percentage of all finished goods purchased were as follows:

 

   2025   2024 
   For the three months ended March 31, 
   2025   2024 
Manufacturer A   52%   36%
Manufacturer B   38%   63%
Other Manufacturers   10%   1%

 

6

 

 

Summary of Significant Accounting Policies

 

There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 27, 2025 that have had a material impact on our condensed consolidated financial statements and related notes.

 

Financial Instruments

 

The Company’s financial instruments consist of cash, accounts receivable, accounts payable, the line of credit and financing agreements. The carrying value of the Company’s financial instruments approximates their fair value.

 

Accounts Receivable and Allowances

 

Accounts receivable are recorded and carried at the original invoiced amount less allowances for credits and for any potential uncollectible amounts due to credit losses. We make estimates of the expected credit and collectability trends for the allowance for credit losses based on our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our customers, current economic conditions, and other factors that may affect our ability to collect from our customers. Expected credit losses are recorded as general and administrative expenses on our condensed consolidated statements of operations. As of March 31, 2025 and December 31, 2024, there was no allowance for credit losses. There was no credit loss expense for the three months ended March 31, 2025 and 2024.

 

Revenue Recognition

 

In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods. The Company applies the following five steps:

 

  1) Identify the contract with a customer
     
    A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers.

 

  2) Identify the performance obligation in the contract
     
    Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer.
     
  3) Determine the transaction price
     
    The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and is generally stated on the approved sales order. Variable consideration, which typically includes rebates or discounts, are estimated utilizing the most likely amount method. Provisions for refunds are generally provided for in the period the related sales are recorded, based on management’s assessment of historical and projected trends.

 

7

 

 

  4)

Allocate the transaction price to performance obligations in the contract

 

Since the Company’s contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated to that single performance obligation.

     
  5) Recognize revenue when or as the Company satisfies a performance obligation
     
   

The Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts are treated as a reduction of sales at the time the sale is recognized. Shipping and handling costs are treated as fulfilment costs and presented in distribution, selling and administrative costs.

 

Payments that are received before performance obligations are recorded are shown as current liabilities.

     
    The Company evaluated the requirement to disaggregate revenue and concluded that substantially all of its revenue comes from a single product, frozen beverages.

 

Storage and Shipping Costs

 

Storage and outbound freight costs are included in selling, marketing and distribution expense. For the three months ending March 31, 2025 and 2024, storage and outbound freight totaled approximately $391,000 and $364,000, respectively.

 

Research and Development

 

Expenditures for research activities relating to product development and improvement are charged to expense as incurred. The Company incurred approximately $18,000 and $30,000 in research and development expense for the three months ended March 31, 2025 and 2024, respectively.

 

Loss Per Share

 

For the three months ended March 31, 2025 and 2024, common stock equivalents have not been included in the calculation of net loss per share as their effect is anti-dilutive as a result of losses incurred.

 

Recent Pronouncements

 

From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We have not determined if the impact of recently issued standards that are not yet effective will have an impact on our results of operations and financial position.

 

Note 2. Inventory

 

Inventory consists of the following:

 

   March 31, 2025   December 31, 2024 
Raw materials and packaging  $519,000   $505,000 
Finished goods   609,000    995,000 
Inventory, net  $1,128,000   $1,500,000 

 

8

 

 

Note 3. Property Plant and Equipment

 

Property and equipment, net consist of the following:

 

   March 31, 2025   December 31, 2024 
Manufacturing equipment  $1,556,000   $1,376,000 
Customer equipment   1,398,000    1,398,000 
Construction in progress   -    152,000 
 Property and equipment, gross   2,954,000    2,926,000 
Less: accumulated depreciation   (2,646,000)   (2,593,000)
Property and equipment, net of depreciation  $308,000   $333,000 

 

Depreciation expense related to these assets was approximately $53,000 and $59,000 for the three-months periods ending March 31, 2025 and 2024, respectively. Depreciation expense in cost of revenue was $7,000 for each of the three-month periods ending March 31, 2025 and 2024.

 

Note 4. Commitments and Contingencies

 

Lease Commitments

 

The Company leases office space under a non-cancellable operating lease which expired on March 31, 2023, and was extended in a series of amendments through September 30, 2025. The Company’s periodic lease cost was approximately $20,000 for each of the three-month periods ending March 31, 2025 and 2024.

 

Legal Proceedings

 

Schreiber Dispute

 

The Company’s products are produced to its specifications through several contract manufacturers. One of the Company’s contract manufacturers (the “Manufacturer”) provided approximately 52% and 42% of the Company’s products in the years ended December 31, 2022 and 2021, respectively, under a Supply Agreement with an initial term through September 2025.

 

Over the course of 2022, the Company experienced numerous quality issues with the case packaging utilized by the Manufacturer. In addition, in July of 2022, the Company began receiving customer complaints about the texture of the Company’s smoothie products produced by the Manufacturer. In response, the Company withdrew product from the market and destroyed on-hand inventory, withholding $499,000 in payments due to the Manufacturer.

 

The Company attempted to resolve the issues based on the contractual procedures described in the Supply Agreement. However, on November 4, 2022, in response to a formal proposal of alternate resolutions, the Company received notification from the Manufacturer that it was denying any responsibility for the defective manufacture of the product. In response, on November 10, 2022, the Company filed a complaint in the United States District Court for the Central District of California, Western Division (the “Complaint”), claiming that the Manufacturer had not met its obligations under the Supply Agreement, and seeking economic damages. In response, the Manufacturer terminated the Supply Agreement. On January 20, 2023, the Company filed a voluntary dismissal of the Complaint which allowed the parties to reach a potential resolution outside of the court system. However, as the parties were once again unable to come to an agreement, the Company re-filed the Complaint in California State Court in August 2023 and continues to progress through the court system.

 

In May 2024, the Company entered into a non-recourse litigation financing arrangement which is expected to be adequate to pursue the Complaint to conclusion.

 

9

 

 

Due to the uncertainties surrounding the claim, the Company is not able to predict either the outcome or a range of reasonably possible recoveries that could result from its actions against the Manufacturer, and no gain contingencies have been recorded. The disruption in its supply resulting from the dispute has and will continue to adversely impact the Company’s results of operations and cash flow until a suitable resolution is reached or new sources of reliable supply at sufficient volume can be identified and developed, the timing of which is uncertain. The Company has mitigated the impact of the supply disruption with the introduction of its single-serve smoothie cartons; however the product format has not been accepted by some customers or as a substitute for the bottle product in all use cases.

 

Other Legal Matters

 

From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently the defendant in one legal proceeding for an amount less than $100,000. Our legal counsel and management believe the probability of a material unfavorable outcome is remote.

 

Note 5. Debt

 

Line of Credit

 

In August 2024, the Company secured receivables financing of $1,500,000 (the “Facility”). Under the Facility, the Company may borrow up to 90% of eligible customer account balances. Amounts outstanding bear interest at a rate prime plus 1.2% and collateral fees of 0.15% and are secured by accounts receivable and inventory. The Facility expires on September 5, 2025, and renews automatically, unless notice is given or received. As of March 31, 2025, there were no borrowings under the Facility. Unamortized deferred financing cost amounted to $7,000 and are included in prepaid expenses and other current assets on the accompanying March 31, 2025 consolidated balance sheet.

 

Financing Agreements

 

In 2024, the Company entered into financing agreements to purchase equipment and software as a service, with imputed or stated interest of 15-19%. Amounts due under the agreements are as follows as of March 31, 2025:

 

      
2025 (9 months)  $96,000 
2026   136,000 
Total payments due   232,000 
Less: interest   (32,000)
 Financing agreements   200,000 
Less: current portion   (103,000)
Financing agreements  $97,000 

 

Convertible Notes

 

From July 2023 to March 2024, the Company executed subscription agreements for substantially all of a $2,000,000 privately placed convertible debt offering. The debt was available to be drawn in 25% increments, maturing on the anniversary of the draw, bearing interest at 10% per annum for the term, regardless of earlier payment or conversion, and was mandatorily convertible as to principal and interest into shares of the Company’s common stock at any time prior to maturity at the greater of $1.20 or 85% of the volume-weighted average price of the common stock for the ten trading days immediately preceding the written notice of the conversion (the “Conversion Price”). If the Company had not exercised the mandatory conversion, the holder of the debt had the option after six months and on up to four occasions to convert all or any portion of the principal and interest into shares of the Company’s common stock at the Conversion Price.

 

10

 

 

On October 23, 2023, the Company drew down $1,390,000 in convertible debt and converted a total of $1,207,000 of principal into 820,160 shares of common stock. Additionally, on December 19, 2023, the Company drew down $470,000 in convertible debt and converted a total of $653,000 of principal and $4,000 of accrued interest into 495,331 shares of common stock. Finally, on March 27 and 29, 2024 the Company drew down $136,000 in convertible debt and converted the total drawn into 124,208 shares, settling all debt. Debt drawdowns included the non-cash settlement of $30,000 and $71,000 in 2023 and 2024, respectively.

 

Note 6. Stockholders’ Equity

 

The following are changes in stockholders’ equity for the three months ended March 31, 2024 and 2025:

 

   Shares   Amount   Capital   (Deficit)   Total 
       Additional         
   Common Stock   paid in   Accumulated     
   Shares   Amount   Capital   (Deficit)   Total 
                     
Balance December 31, 2023    14,420,105   $      -   $63,299,000   $(60,796,000)  $2,503,000 
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding   175,562    -    (20,000)   -    (20,000)
Equity-based compensation expense    -    -    366,000    -    366,000 
Conversion of debt and interest (Note 5)   124,208    -    136,000    -    136,000 
Net loss    -    -    -    (449,000)   (449,000)
Balance March 31, 2024   14,719,875   $-   $63,781,000   $(61,245,000)  $2,536,000 

 

       Additional         
   Common Stock   paid in   Accumulated     
   Shares   Amount   Capital   (Deficit)   Total 
                     
Balance December 31, 2024   14,746,172   $      -   $64,199,000   $(63,621,000)  $578,000 
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding   121,082    -    (160,000)   -    (160,000)
Equity-based compensation expense   -    -    158,000    -    158,000 
Registered issuance of common stock   1,052,793         2,974,000         2,974,000 
Net loss   -    -    -    (761,000)   (761,000)
Balance March 31, 2025   15,920,047   $-   $67,171,000   $(64,382,000)  $2,789,000 

 

On February 5, 2025, the Company entered into securities purchase agreements with several investors, pursuant to which the Company sold an aggregate of 1,052,793 shares of common stock at a price of $2.85 per share in a registered direct offering.

 

Warrants

 

During the three months ended March 31, 2025, 121,076 warrants at a weighted average exercise price of $3.51 per share expired. There are no warrants outstanding as of March 31, 2025.

 

Equity Incentive Plan

 

As of March 31, 2025, the Company has $409,000 of total unrecognized share-based compensation expense relative to unvested options, stock awards and stock units, which is expected to be recognized over the remaining weighted average period of 3.0 years.

 

11

 

 

Stock Options

 

The following is a summary of stock option activity for the three months ended March 31, 2025:

 

   Number of
Options
   Weighted
average exercise
price per share
   Remaining
term in years
 
Outstanding on December 31, 2024   710,323   $5.04    5.5 
Issued   40,071   $2.74      
Forfeited   -           
Expired   (3,102)  $10.01      
Outstanding on March 31, 2025   747,292   $4.89    5.5 
                
Exercisable, March 31, 2025   520,874   $5.73    3.9 

 

The fair value of the options issued was calculated using the Black-Scholes option pricing model, based on the following:

 

   2025 
Expected term (in years)   8.0 
Expected volatility   97.4%
Risk-free interest rate   4.4%
Expected dividends  $- 
Weighted average grant date fair value per share  $2.36 

 

Restricted Stock

 

The following is a summary of restricted stock award and restricted stock unit activity for the three months ended March 31, 2025:

 

   Number of shares   Weighted average
grant date fair value
 
Unvested at January 1, 2025   61,873   $2.72 
Granted   44,880   $2.69 
Forfeited   (9,960)  $(2.51)
Vested   (18,873)  $(4.80)
Unvested at March 31, 2025   77,920   $2.23 

 

Performance Share Units

 

The Company issues performance share units (“PSUs”) that represent shares potentially issuable based upon Company and individual performance in the years of issuance.

 

12

 

 

The following table summarizes the activity for the Company’s unvested PSUs for the three months ended March 31, 2025:

 

   Number of shares   Weighted average
grant date fair value
 
Unvested January 1, 2025   157,694   $1.20 
Vested   (157,694)     
Unvested at March 31, 2025   -   $- 

 

Note 7. Income Taxes

 

ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all the deferred tax assets will not be recognized. Accordingly, at this time the Company has placed a valuation allowance on all tax assets. As of March 31, 2025, the estimated effective tax rate for 2025 was zero.

 

There are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2019 through the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the statement of operations.

 

For the three months ending March 31, 2025 and 2024, the Company did not incur any interest and penalties associated with tax positions. As of March 31, 2025, the Company did not have any significant unrecognized uncertain tax positions.

 

Note 8. Liquidity

 

During the three months ending March 31, 2025, the Company used cash in operations of $506,000. As of March 31, 2025, the Company had $1,872,000 of cash.

 

The Company has a history of operating losses and negative cash flow, which are expected to improve with growth. As described more fully in Note 4, the dispute and subsequent contract termination with the Manufacturer has resulted in limitations in the Company’s ability to procure certain products necessary to achieve our growth projections and in elevated legal costs.

 

To mitigate the impact of procurement constraints, the Company builds inventory in anticipation of third quarter seasonal requirements, and has invested in materials necessary to carry out trials and initial production runs at new co-manufacturers. The Company secured a receivables-based line of credit in August 2024 of $1,500,000, with no outstanding borrowing as of March 31, 2025. Management expects that the cash cycle will shorten as additional contracted capacity improves production volume and efficiency in 2025. Additionally, in May 2024, the Company obtained non-recourse litigation financing to allow vigorous pursuit of the complaint against the Manufacturer without further expense to the Company. Finally, as described in Note 6, the Company raised $3,000,000 through the sale of the Company’s common stock in February 2025.

 

The financial position at March 31, 2025 and historical results raise substantial doubt about the Company’s ability to continue as a going concern. As described, the Company has completed steps to mitigate dispute related issues and raise capital. The actions taken have resulted in the alleviation of the substantial doubt about the Company’s ability to continue as a going concern.

 

13

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion should be read in conjunction with the financial information included elsewhere in this Quarterly Report on Form 10-Q (this “Report”), including our unaudited condensed consolidated financial statements and the related notes and with our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 27, 2025, and other reports that we file with the SEC from time to time.

 

References in this Quarterly Report on Form 10-Q to “us”, “we”, “our” and similar terms refer to Barfresh Food Group Inc.

 

Cautionary Note Regarding Forward-Looking Statements

 

This discussion includes forward-looking statements, as that term is defined in the federal securities laws, based upon current expectations that involve risks and uncertainties, such as plans, objectives, expectations, and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. Words such as “anticipate”, “estimate”, “plan”, “continuing”, “ongoing”, “expect”, “believe”, “intend”, “may”, “will”, “should”, “could” and similar expressions are used to identify forward-looking statements.

 

We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond our control, which may influence the accuracy of the statements and the projections upon which the statements are based. Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

 

Critical Accounting Policies

 

Our consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

Results of Operations

 

Results of Operation for the Three Months Ended March 31, 2025 as Compared to the Three Months Ended March 31, 2024

 

Revenue and cost of revenue

 

Revenue increased $101,000, or 4%, to $2,930,000 in 2025 as compared to $2,829,000 in 2024. Our revenue in 2025 benefited from increased sales of our bottled Twist & Go smoothies.

 

We have been able to expand our capacity on a limited basis at our existing smoothie bottle manufacturer and have been developing an additional manufacturer relationship since the fourth quarter of 2024, after the candidate we contracted with in July 2024 was unable to successfully produce product at scale. We expect expanded capacity to become available in the second half of 2025, subject to the risks and uncertainties associated with pre-production activities.

 

Cost of revenue increased $371,000, or 22%, to $2,030,000 in 2025 as compared to $1,659,000 in 2024. Cost of revenue increased at a higher rate compared to revenue due to trial costs at our new manufacturer and elevated costs to supply product in a sub-optimal manner while the production process at our new manufacturer is under development. The increase was partially offset by the non-recurrence of costs to relocate our single-serve manufacturing line, which amounted to $45,000 in 2024.

 

Our gross profit was $900,000 (31%) and $1,170,000 (41%) for 2025 and 2024, respectively. Excluding production relocation costs, our gross profit was $1,215,000 in 2024 (43%). The reduction in gross margin is a result of product mix and new manufacturer trial and developments costs.

 

14

 

 

Selling, marketing and distribution expense

 

   Three months
ended
   Three months
ended
         
   March 31, 2025   March 31, 2024   Change   Percent 
Sales and marketing  $433,000   $330,000   $103,000    31%
Storage and outbound freight   391,000    364,000    27,000    7%
   $824,000   $694,000   $130,000    19%

 

Our operations in 2025 were primarily directed towards increasing sales and expanding our distribution network.

 

Selling, marketing and distribution expense increased approximately $130,000 (19%) from approximately $694,000 in 2024 to $824,000 in 2025.

 

Sales and marketing expense increased approximately $103,000 (31%) from approximately $330,000 in 2024 to $433,000 in 2025. The increase is a result of higher personnel costs and broker commissions due to expansion of the broker network, as well as an increase in sample expense due to the introduction of our Pop & Go freeze pops.

 

Storage and outbound freight expense increased approximately $27,000 (7%) from approximately $364,000 in 2024 to $391,000 in 2024, slightly higher than the 4% rate of increase in revenue primarily because of freight inefficiencies resulting from supply constraints.

 

General and administrative expense

 

   Three months
ended
   Three months
ended
         
   March 31, 2025   March 31, 2024   Change   Percent 
Personnel costs  $372,000   $262,000   $110,000    42%
Stock-based compensation   158,000    303,000    (145,000)   -48%
Legal, professional and consulting fees   81,000    157,000    (76,000)   -48%
Research and development   19,000    30,000    (11,000)   -37%
Other general and administrative expenses   117,000    103,000    14,000    14%
   $747,000   $855,000   $(108,000)   -13%

 

General and administrative expenses decreased approximately $108,000 (13%) from approximately $855,000 in 2024 to $747,000 in 2025.

 

Personnel cost represents the cost of employees including salaries, bonuses, employee benefits and employment taxes. Personnel cost increased by approximately $110,000 (42%) from approximately $262,000 in 2024 to $372,000 in 2025. The increase in personnel cost resulted from increased head count, and acceleration of employer payroll taxes due to vesting of stock-based compensation.

 

Stock-based compensation decreased by approximately $145,000 (48%) from $303,000 in 2024 to $158,000 in 2025 as a result of lower expected attainment under our performance stock unit program.

 

Legal, professional and consulting fees decreased by approximately $76,000 (48%) from $157,000 in 2024 to $81,000 in 2025 due to a reduction in dispute related legal costs that are paid through non-recourse litigation financing that was arranged in May 2024.

 

Other general and administrative expenses increased by approximately $14,000 (14%) due to increased information technology costs.

 

15

 

 

Net loss

 

We had net losses of approximately $761,000 and $449,000 for the three-month periods ending March 31, 2025 and 2024, respectively. The increase in net loss of approximately $312,000 was primarily due to the 10.7 percentage point reduction in gross margin, from 41.4% to 30.7%, resulting in a reduction in gross profit of $270,000. We expect our gross margin to normalize in the second half of 2025 as new co-manufacturers are operating at full capacity and capability, improving our supply and cost structure.

 

Liquidity and Capital Resources

 

From July 2023 to March 2024, we executed subscription agreements for substantially all of a $2,000,000 privately placed convertible debt offering. The debt was available to be drawn in 25% increments, maturing on the anniversary of the draw, bearing interest at 10% per annum for the term, regardless of earlier payment or conversion, and was mandatorily convertible as to principal and interest into shares of our common stock at any time prior to maturity at the greater of $1.20 or 85% of the volume-weighted average price of the common stock for the ten trading days immediately preceding the written notice of the conversion (the “Conversion Price”). If we had not exercised the mandatory conversion, the holder of the debt had the option after six months and on up to four occasions to convert all or any portion of the principal and interest into shares of our common stock at the Conversion Price. On October 23, 2023, we issued $1,390,000 of convertible notes pursuant to the subscription agreements, and immediately converted $1,207,000 of principal and interest into approximately 820,000 shares of common stock. Additionally, on December 19, 2023, we drew down $470,000 in convertible debt and converted a total of $653,000 of principal and $4,000 of accrued interest into 495,331 shares of common stock. Finally, on March 27 and 29, 2024, we drew down $136,000 in convertible debt and converted the total drawn into 124,208 shares, settling all debt.

 

On February 5, 2025, we entered into securities purchase agreements with several investors, pursuant to which we sold an aggregate of 1,052,793 shares of common stock at a price of $2.85 per share in a registered direct offering.

 

During the three months ended March 31, 2025, we used $506,000 in operations. Our net loss adjusted for non-cash operating expenses was a loss of $525,000, while changes in current assets and liabilities generated $19,000 primarily because of a reduction of $372,000 in inventory and increases in accounts payable and accrued expense of $222,000 and $218,000, respectively, partially offset by an increase in accounts receivable of $670,000.

 

As of March 31, 2025, we had working capital of $2,848,000 compared with $606,000 at December 31, 2024, both excluding disputed accounts payable of $499,000 resulting from our dispute with the Manufacturer. The increase in working capital is primarily due to capital raised in the three months ended March 31, 2025 through the sale of common stock, partially offset by losses incurred in the three months ended March 31, 2025.

 

Our liquidity needs will depend on how quickly we are able to profitably ramp up sales, as well as our ability to control and reduce variable operating expenses, and to continue to control fixed overhead expense.

 

Our operations to date have been financed by the sale of securities, the issuance of convertible debt and the issuance of short-term debt. If we are unable to generate sufficient cash flow from operations with the capital raised we will be required to raise additional funds either in the form of equity or in the form of debt. There are no assurances that we will be able to generate the necessary capital to carry out our current plan of operations.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expense, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required because we are a smaller reporting company.

 

16

 

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Securities and Exchange Act of 1934 Rule 13(a)-15(e). Disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act has been appropriately recorded, processed, summarized, and reported on a timely basis and are effective in ensuring that such information is accumulated and communicated to the Company’s management, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures as of March 31, 2025, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

None.

 

PART II- OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

As described in Note 4, the Company has an on-going dispute with the Manufacturer, the outcome of which cannot be predicted at this time.

 

From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently the defendant in one legal proceeding for an amount less than $100,000. Our legal counsel and management believe a material unfavorable outcome to be remote.

 

Item 1A. Risk Factors.

 

Not required because we are a smaller reporting company.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

17

 

 

Item 6. Exhibits.

 

Exhibit No.   Description
     
10.1  

Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 from the Current Report on Form 8-K filed February 6, 2025)

 

31.1   Certification of Principal Executive Officer pursuant to Rule 13a-14(a) (filed herewith)
     
31.2   Certification of Principal Financial Officer pursuant to Rule 13a-14(a) (filed herewith)
     
32.1   Certification pursuant to 18 U.S.C. Section 1350 (furnished herewith)
     
101.INS   Inline XBRL Instance Document*
101.SCH   Inline XBRL Taxonomy Extension Schema Document*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
    *XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
     
    In accordance with SEC Release 33-8238, Exhibit 32.1 is furnished and not filed.

 

18

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BARFRESH FOOD GROUP INC.
     
Date: May 1, 2025 By: /s/ Riccardo Delle Coste
    Riccardo Delle Coste
    Chief Executive Officer
    (Principal Executive Officer)
     
Date: May 1, 2025 By: /s/ Lisa Roger
    Chief Financial Officer
    (Principal Financial Officer)

 

19